How has been the historical performance of Natural Biocon?

Answer:The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years.

Breakdown:
Natural Biocon's net sales have seen significant growth from Mar'20, where it recorded no sales, to Mar'25 with sales of 8.35 Cr, although it peaked at 13.53 Cr in Mar'24. The total operating income followed a similar trajectory, increasing from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25. However, total expenditure also rose, reaching 8.29 Cr in Mar'25 from just 0.03 Cr in Mar'20. Operating profit, while positive in recent years, has declined from 0.24 Cr in Mar'23 to 0.06 Cr in Mar'25. Profit after tax has also decreased from 0.18 Cr in Mar'23 to 0.04 Cr in Mar'25. The company's total assets increased significantly from 12.71 Cr in Mar'20 to 38.52 Cr in Mar'25, driven by a rise in non-current investments to 21.12 Cr in Mar'25. Total liabilities also grew, reaching 38.52 Cr in Mar'25, with a notable increase in trade payables. The cash flow from operating activities turned positive at 1.00 Cr in Mar'25, while cash flow from investing activities showed a significant outflow of -21.00 Cr, indicating substantial investments. Overall, Natural Biocon's performance reflects a company in growth mode, albeit with challenges in profitability in recent periods.